High Purity Monophenyl Ester for Antiviral Drug Synthesis
Your key intermediate for advanced antiviral drug production, ensuring purity and efficacy.
Get a Quote & SampleProduct Core Value
Monophenyl Ester Intermediate
This high-purity white powder serves as a critical building block in the synthesis of Tenofovir disoproxil fumarate, a cornerstone in the treatment of HIV. Its precisely controlled specifications guarantee optimal performance in complex pharmaceutical manufacturing processes.
- The synthesis of Tenofovir disoproxil fumarate relies on this key intermediate to ensure the final drug's potency and safety.
- As a high purity white powder intermediate, it meets stringent quality control standards for pharmaceutical applications.
- This compound is essential for antiviral drug development, contributing directly to combating viral infections.
- Sourcing this Tenofovir intermediate from reliable suppliers is crucial for consistent API production.
Advantages Offered
Exceptional Purity
With a purity of ≥99.0%, this pharmaceutical intermediate white powder minimizes side reactions and ensures the quality of the final drug product.
Critical for Antiviral Synthesis
It's an indispensable component for the tenofovir synthesis raw material chain, supporting the production of life-saving medications.
Reliable Supply Chain
We are a trusted high purity 379270-35-6 supplier, offering consistent quality and availability for your production needs.
Key Applications
Antiviral Drug Manufacturing
Plays a vital role as a monophenyl ester intermediate for tenofovir synthesis, directly contributing to the efficacy of antiviral treatments.
HIV Treatment Development
Essential for the production of Tenofovir disoproxil fumarate, a key medication in managing HIV infection and improving patient outcomes.
Pharmaceutical R&D
Used in research and development to explore new synthesis routes and optimize production of antiviral compounds.
Chemical Synthesis
Its well-defined chemical properties make it a valuable compound for various complex organic synthesis projects in the pharmaceutical sector.